Yoshino Kawaguchi

Shomachi, 7708505, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization.

Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component Optimization.

Journal: ACS nano

Published: July 23, 2025

Inflammatory mediators of mRNA vaccine-induced adverse reactions in mice.

Inflammatory mediators of mRNA vaccine-induced adverse reactions in mice.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 21, 2025

Impact of pre-existing anti-polyethylene glycol (PEG) IgM on biodistribution and humoral response of intramuscularly administered PEGylated mRNA loaded lipid nanoparticle.

Impact of pre-existing anti-polyethylene glycol (PEG) IgM on biodistribution and humoral response of intramuscularly administered PEGylated mRNA loaded lipid nanoparticle.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 03, 2025

A spleen-targeted vaccine for SARS-CoV-2 - Inducting neutralizing antibodies in mice.

A spleen-targeted vaccine for SARS-CoV-2 - Inducting neutralizing antibodies in mice.

Journal: Journal of pharmaceutical sciences

Published: October 27, 2024

An in vitro nanocarrier-based B cell antigen loading system; tumor growth suppression via transfusion of the antigen-loaded B cells in vivo.

An in vitro nanocarrier-based B cell antigen loading system; tumor growth suppression via transfusion of the antigen-loaded B cells in vivo.

Journal: International journal of pharmaceutics

Published: September 18, 2024

Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction.

Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction.

Journal: NPJ vaccines

Published: March 17, 2024

Development of a Nanocarrier-Based Splenic B Cell-Targeting System for Loading Antigens in Vitro.

Development of a Nanocarrier-Based Splenic B Cell-Targeting System for Loading Antigens in Vitro.

Journal: Biological & pharmaceutical bulletin

Published: July 05, 2022

Development of an Antigen Delivery System for a B Cell-Targeted Vaccine as an Alternative to Dendritic Cell-Targeted Vaccines.

Development of an Antigen Delivery System for a B Cell-Targeted Vaccine as an Alternative to Dendritic Cell-Targeted Vaccines.

Journal: Chemical & pharmaceutical bulletin

Published: May 01, 2022

Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes.

Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes.

Journal: Biological & pharmaceutical bulletin

Published: June 03, 2021

Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: A possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodies.

Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: A possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodies.

Journal: International journal of pharmaceutics

Published: January 08, 2021

Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice.

Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 29, 2020

Complement activation induced by PEG enhances humoral immune responses against antigens encapsulated in PEG-modified liposomes.

Complement activation induced by PEG enhances humoral immune responses against antigens encapsulated in PEG-modified liposomes.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 30, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026